SR Protein Expression and CD44 Splicing Pattern in Human Breast Tumours (original) (raw)
References
Murphy LC, Dotzlaw H, Leygue E, Coutts A, Watson P: The pathophysiological role of estrogen receptor variants in human breast cancer. J Steroid Biochem Mol Biol 65: 175–180, 1998 Google Scholar
Huang A, Leygue E, Dotzlaw H, Murphy LC, Watson PH: Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat 58: 219–225, 1999 Google Scholar
Hole AK, Belkhiri A, Snell LS, Watson PH: CD44 variant expression and estrogen receptor status in breast cancer. Breast Cancer Res Treat 43: 165–173, 1997 Google Scholar
Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA: The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 4: 567–576, 1998 Google Scholar
Sharp PA: RNA splicing and genes. JAMA 260: 3035–3041, 1988 Google Scholar
Hastings ML, Krainer AR: Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 13: 302–309, 2001 Google Scholar
Fu XD, Maniatis T: Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256: 535–538, 1992 Google Scholar
Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR: Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14: 4336–4349, 1995 Google Scholar
Graveley BR: Sorting out the complexity of SR protein functions. RNA 6: 1197–1211, 2000 Google Scholar
Manley JL, Tacke R: SR proteins and splicing control. Genes Dev 10: 1569–1579, 1996 Google Scholar
Zahler AM, Neugebauer KM, Lane WS, Roth MB: Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260: 219–222, 1993 Google Scholar
Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292–5297, 1991 Google Scholar
Hiller T, Snell L, Watson PH: Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques 21: 38–40, 42, 44, 1996 Google Scholar
Watson PH, Snell L, Parisien M: The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ 155: 281–283, 1996 Google Scholar
Schagger H, von Jagow G: Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368–379, 1987 Google Scholar
Tanaka M, Herr W: Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60: 375–386, 1990 Google Scholar
Gunthert U: CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184: 47–63, 1993 Google Scholar
Zahler AM, Lane WS, Stolk JA, Roth MB: SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 6: 837–847, 1992 Google Scholar
Murphy LC, Leygue E, Dotzlaw H, Douglas D, Coutts A, Watson PH: Oestrogen receptor variants and mutations in human breast cancer. Ann Med 29: 221–234, 1997 Google Scholar
Leygue E, Dotzlaw H, Watson PH, Murphy LC: Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59: 1175–1179, 1999 Google Scholar
Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer 80: 379–382, 1999 Google Scholar
Sanford JR, Bruzik JP: Developmental regulation of SR protein phosphorylation and activity. Genes Dev 13: 1513–1518, 1999 Google Scholar
Gui JF, Lane WS, Fu XD: A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369: 678–682, 1994 Google Scholar
Stickeler E, Kittrell F, Medina D, Berget SM: Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574–3582, 1999 Google Scholar
Ghigna C, Moroni M, Porta C, Riva S, Biamonti G: Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 58: 5818–5824, 1998 Google Scholar
Bell MV, Cowper AE, Lefranc MP, Bell JI, Screaton GR: Influence of intron length on alternative splicing of CD44. Mol Cell Biol 18: 5930–5941, 1998 Google Scholar
Graveley BR, Hertel KJ, Maniatis T: A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J 17: 6747–6756, 1998 Google Scholar
Schaal TD, Maniatis T: Selection and characterization of premRNA splicing enhancers: identification of novel SR proteinspecific enhancer sequences. Mol Cell Biol 19: 1705–1719, 1999 Google Scholar
Cowper AE, Caceres JF, Mayeda A, Screaton GR: Serinearginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing. J Biol Chem 276: 48908–48914, 2001 Google Scholar
Du C, McGuffin ME, Dauwalder B, Rabinow L, Mattox W: Protein phosphorylation plays an essential role in the regulation of alternative splicing and sex determination in Drosophila. Mol Cell 2: 741–750, 1998 Google Scholar
Xiao SH, Manley JL: Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 11: 334–344, 1997 Google Scholar
Nayler O, Stamm S, Ullrich A: Characterization and comparison of four serine-and arginine-rich (SR) protein kinases. Biochem J 326(Pt 3): 693–700, 1997 Google Scholar
Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C, Tazi J: Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381: 80–82, 1996 Google Scholar
Misteli T, Spector DL: Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol Biol Cell 7: 1559–1572, 1996 Google Scholar